Search   
MSDS  : 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethyl ester
CAS  : 29177-84-2
SYNONYMS  : * CM 6912 * Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-ca rboxylate * Ethyl fluclozepate * Ethyl loflazepate * Loflazepic acid, ethyl ester * Victan
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : DE8760000
CHEMICAL NAME : 1H-1,4-Benzodiazepine-3-carboxylic acid,
7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethyl
ester
CAS REGISTRY NUMBER : 29177-84-2
BEILSTEIN REFERENCE NO. : 0765264
REFERENCE : 5-25-08-00124 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C18-H14-Cl-F-N2-O3
MOLECULAR WEIGHT : 360.79
WISWESSER LINE NOTATION : T67 GMV JN IHJ CG IVO2 KR BF
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* CM 6912
* Ethyl
7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-ca
rboxylate
* Ethyl fluclozepate
* Ethyl loflazepate
* Loflazepic acid, ethyl ester
* Victan

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1411,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 645 mg/kg
TOXIC EFFECTS :
Behavioral - antipsychotic
REFERENCE :
IJCPB5 International Journal of Clinical Pharmacology, Therapy and
Toxicology. (Dustri-Verlag Dr. Karl Feistle, Postfach 49, D-8024
Munich-Deisenhofen, Fed. Rep. Ger.) V.6-10, 1972-74; V.18- 1980-
Volume(issue)/page/year: 19,453,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1411,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5506 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1411,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 712 mg/kg
TOXIC EFFECTS :
Behavioral - antipsychotic
REFERENCE :
IJCPB5 International Journal of Clinical Pharmacology, Therapy and
Toxicology. (Dustri-Verlag Dr. Karl Feistle, Postfach 49, D-8024
Munich-Deisenhofen, Fed. Rep. Ger.) V.6-10, 1972-74; V.18- 1980-
Volume(issue)/page/year: 19,453,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1795 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1411,1986

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Behavioral - sleep
Behavioral - somnolence (general depressed activity)
Behavioral - muscle weakness
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1503,1986

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 48 gm/kg/30D-C
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - true cholinesterase
Biochemical - Metabolism (Intermediary) - Plasma proteins not involving
coagulation
Related to Chronic Data - death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1418,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 9100 mg/kg/26W-C
TOXIC EFFECTS :
Blood - other changes
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - peptidases
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - isomerases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1463,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 9100 mg/kg/13W-C
TOXIC EFFECTS :
Liver - changes in liver weight
Kidney, Ureter, Bladder - changes in bladder weight
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1524,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1138 mg/kg/26W-C
TOXIC EFFECTS :
Liver - changes in liver weight
Kidney, Ureter, Bladder - other changes in urine composition
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1573,1986

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 2640 mg/kg
SEX/DURATION : female 17-22 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
Reproductive - Effects on Newborn - physical
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1683,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 2200 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1655,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 920 mg/kg
SEX/DURATION : female 15 day(s) pre-mating
female 0-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1635,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 1300 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 20,1655,1986

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1H-1,4-Benzodiazepine-1-carboxamide,2,3-dihydro-N-methyl-7-nitro-2-oxo-5-phenyl- 27016-91-7
1H-1,5-Benzodiazepine-1-carboxamide,2,3,4,5-tetrahydro-2-methyl-4-oxo- 89647-50-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassiumsalt, compd. with potassium hydroxide 57109-90-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethylester 29177-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-chlorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-85-3
5H-Benzocyclohepten-7-amine, 6,7-dihydro-N-methyl-,hydrochloride, (+)- 62819-45-8
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, monopotassiumsalt 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, phenyl ester 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-nitro-2-oxo-5-phenyl-, monopotassiumsalt 5571-84-6
1H-1,5-Benzodiazepine-2-carboxylic acid,5,5'-(1,2-dioxo-1,2-ethanediyl)bis(2,3,4,5-tetrahydro-2-methyl-4-phenyl-, diethyl ester 144401-02-5
1H-1,4-Benzodiazepine-3-carboxylic acid,2-hydroxy-7-nitro-5-phenyl-, monopotassium salt,compd. with potassium hydroxide 24477-47-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-acetyl-4-methyl-, ethyl ester 121635-52-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-acetyl-2-methyl-4- phenyl-,ethyl ester 92911-27-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-benzoyl-4-methyl-, ethyl ester 121635-55-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-benzoyl-2-methyl-4- phenyl-,ethyl ester 92942-83-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((bis(2-methylpropyl)amino)acetyl)-4-methyl-, ethyl ester 121635-59-4
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-methyl-9-phenyl-, hydrochloride 62819-50-5
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(chloroacetyl)-4-methyl-, ethylester 121635-53-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(chloroacetyl)-2-methyl-4-phenyl-, ethyl ester 92911-28-9
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(4-chlorobenzoyl)-4-methyl-,ethyl ester 121635-56-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(4-chlorobenzoyl)-2-methyl-4-phenyl-, ethyl ester 92911-29-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((diethylamino)acetyl)-4-methyl-, ethyl ester 121635-57-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((dipropylamino)acetyl)-4-methyl-, ethyl ester 121635-58-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-, ethyl ester 87896-36-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(4-morpholinylacetyl)-,ethyl ester 121635-60-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-oxobutyl)-, ethylester 121635-54-9
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, ethyl ester 98987-10-1
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-2-propenyl-, hydrochloride 62819-69-6
1H-1,5-Benzodiazepine-5-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-2-oxo-, methyl ester 89647-48-3
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, phenyl ester 98987-11-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-5-(1-oxo-3-phenyl-2-propentyl)-4-phenyl-, ethyl ester 144401-01-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-, ethyl ester 87918-91-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-5-(1-oxopropyl)-, ethyl ester 92942-82-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-piperidinylacetyl)-,ethyl ester 121635-61-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl- 87896-33-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, ethyl ester 87896-35-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, methyl ester 87896-34-2
3H-1,4-Benzodiazepine,7-chloro-2-(cyclopropylamino)-5-phenyl-, 4-oxide 3864-80-0
5H-Benzocyclohepten-7-amine,6,7,8,9-tetrahydro-5-(4-aminophenoxy)-N,N-dimethyl-,dihydrochloride, cis- 72575-47-4
3H-1,4-Benzodiazepine,7-chloro-2-((cyclopropylmethyl)amino)-5-phenyl-,4-oxide 15687-07-7
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl- 2898-12-6
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl-,monohydrochloride 2898-11-5
1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-5-phenyl 1694-78-6
3H-1,4-Benzodiazepine,7-chloro-2-dimethylamino-5-phenyl-, 4-oxide 3693-14-9
3H-1,4-Benzodiazepine,7-chloro-2-(N-methoxymethyl-N-methylamino)-5-phenyl-,4-oxide 69353-35-1
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide 58-25-3
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide andbarbituric acid, 5-ethyl-5-phenyl- (5:3) 63917-56-6
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide,monohydrochloride 438-41-5
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide, mixed withsodium nitrite (1:1) 104639-49-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net